Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. ASCO, Abst: 3120 Poster: 112, 6/2022.

A Trabolsi; Dave S.B. Hoon; See all authors in notes

Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. ASCO, Abst: 3120 Poster: 112, 6/2022.

A Trabolsi, Dave S.B. Hoon, See all authors in notes

Research output: Contribution to conference › Abstract

Original language	American English
State	Published - 2022

Cite this

@conference{471edbfe15f148bb9db4cc88f8d85bfa,

title = "Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. ASCO, Abst: 3120 Poster: 112, 6/2022.",

author = "A Trabolsi and Hoon, {Dave S.B.} and {See all authors in notes}",

note = "286. Trabolsi A, Arumov A, Yin J, Halmos B, Brodskiy P, Oberley MJ, Hoon DSB, Liu SV, Wei S, Kang I, Schatz JH",

year = "2022",

language = "American English",

}

TY - CONF

T1 - Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. ASCO, Abst: 3120 Poster: 112, 6/2022.

AU - Trabolsi, A

AU - Hoon, Dave S.B.

AU - See all authors in notes,

N1 - 286. Trabolsi A, Arumov A, Yin J, Halmos B, Brodskiy P, Oberley MJ, Hoon DSB, Liu SV, Wei S, Kang I, Schatz JH

PY - 2022

Y1 - 2022

M3 - Abstract

ER -